PathMD

PathMD

Search
Skip to content
  • Immunohistochemistry
  • WHO Heme Classification
  • CK7 / CK20 Tables
  • Organ Systems
  • About
Organ Systems, Breast, IHC Panels

Breast – IHC

October 10, 2017 peferguson

There are multiple situations where immunohistochemistry can serve an important role in breast disease.  These include:  differentiation of lesion types (e.g. UTH vs. ADH), identifying invasion (e.g DCIS vs. DCIS with invasion), and predictive/prognostic information (e.g. ER/PR/HER-2).

  • Breast – Normal IHC Staining
  • Breast Specific Markers
  • DCIS vs. Invasion
  • UTH vs. ADH
  • DCIS vs. LCIS
  • Predictive/Prognostic Markers

Share this:

  • Share on X (Opens in new window) X
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Share on LinkedIn (Opens in new window) LinkedIn

Related

Post navigation

Previous PostBreast Lesions and Risk of Developing an Invasive CarcinomaNext PostBreast – Epithelial Proliferations

PathMD E-Mail Signup

Poll

What is your most commonly used breast specific IHC marker?
Results

Check-out more in-depth information on these markers the PathMD IHC section of our website/app.

Search PathMD

Important Links

Cancer Protocols

Am. Board of Path. 

PathMD Blog

PathMD
Proudly powered by WordPress